Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

TmCD19-IL18 in CD19+ Cancers

NCT05989204

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia

NCT05303792

Conditions
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +21 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

The Brain Health Champion Study

NCT03772977

Conditions
At Risk for Cognitive Decline, Brain Diseases, Central Nervous System Diseases, +19 more
Locations
  • Brigham and Women's Hospital, Department of Neurology Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

NCT04419519

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

NCT03213652

Conditions
Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma

NCT04712097

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology, Inc Fort Wayne, Indiana, United States
  • Investigative Clinical Research of Indiana, LLC Noblesville, Indiana, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

NCT05451771

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • New York Presbyterian Hospital/Columbia University Irving Medical Center New York, United States
View Trial Details

Related conditions